- stock
- bulk
- Price
Supplier Type
- Manufacturer
- Trader
- custom synthesis
- Reagent
- contract manufacturer
Supplier Region
- Hyderabad(32)
- Gujarat(15)
- Bangalore(2)
- Telangana(3)
- Maharashtra(9)
- Andhra Pradesh(2)
- Mumbai(15)
- Tamil Nadu(1)
- Pune(2)
- Haryana(3)
- Ahmedabad(5)
- Vadodara(1)
- Delhi(1)
- Karnataka(3)
- Uttar Pradesh(1)
- Kolkata(1)
- New Delhi(3)
Purity
- VETRANAL?, analytical standard
- United States Pharmacopeia (USP) Reference Standard
- thyroid hormone analog
- technical grade, 90%
- ReagentPlus?, 99%
- Pure
- powder
- phyproof? Reference Substance
- pharmaceutical secondary standard, certified reference material
- Pharmaceutical Secondary Standard
- N-methylpyrrolidinone HCl 98.00%
- NLT 98%
- NLT 95%
- more than 95 % (in HPLC)
- more than 90%
- lyophilized powder
- HPLC)
- Greater than 99%
- GC)
- for synthesis
- European Pharmacopoeia (EP) Reference Standard
- contains 0.5% BHT as stabilizer, technical grade
- Chemically Pure
- certified reference material, pharmaceutical secondary standard
- Certified Reference Material
- Cell-permeable adenylate cyclase inhibitor.
- British Pharmacopoeia (BP) Reference Standard
- b-[10-(1-naphthalenyl)-9-anthracenyl]- 97%
- Avanti Polar Lipids
- analytical standard
- AldrichCPR
- 99.99%
- 99.94%
- 99.93%
- 99.90%
- 99.9%
- 99.77%
- 99.74%
- 99.60%
- 99.50%
- 99.40%
- 99.36%
- 99.35%
- 99.34%
- 99.30%
- 99.25%
- 99.19%
- 99.13%
- 99.00%
- >99.0%(T)
- >99.0%(GC)(T)
- >99.0%(GC)
- ≥99.0% (T)
- >99%
- ≥99%
- 99%
- 98+
- 98.94%
- 98.30%
- 98.00%
- >98.0%(T)(HPLC)
- >98.0%(T)
- >98.0%(N)
- >98.0%(HPLC)(N)
- >98.0%(HPLC)
- >98.0%(GC)(T)
- >98.0%(GC)(N)
- >98.0%(GC)
- ≥98.0% (CHN)
- 98%+
- ≥98% (HPLC)
- 98%
- ≥98%
- 98 %
- 97-99%
- 97.39%
- 97.00%
- >97.0%(T)(N)
- >97.0%(T)(HPLC)
- >97.0%(T)
- >97.0%(N)
- >97.0%(HPLC)(N)
- >97.0%(HPLC)
- >97.0%(GC)(T)
- >97.0%(GC)
- ≥97.0% (T)
- ≥97% (HPLC), powder
- 97%
- >97%
- ≥97%
- >96.0%(T)(HPLC)
- >96.0%(T)
- >96.0%(HPLC)
- >96.0%(GC)(T)
- >96.0%(GC)
- ≥96.0% (GC)
- >96%
- 96%
- 95.29%
- 95.00%
- >95.0%(T)(HPLC)
- >95.0%(GC)(T)
- >95.0%(GC)
- ≥95% (oligomer purity)
- ≥95% (HPLC)
- 95%
- ≥95%
- >95%
- ≥94%
- 93.60%
- 92%
- ≥90% (HPLC)
- 90%
- 90 % Above
- 4-[(2r)-2-(chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)- 95%
- 2-[[(1,1-dimethylethoxy)carbonyl]amino]-3-nitro-methyl ester 95%
- 1-stearoyl-2-palmitoyl-sn-glycero-3-phosphocholine, powder
- 1,1-dimethylethyl ester 95%
Package
- 10μg
- 1mg
- 5mg
- 10MG-F
- 10mg
- 15mg
- 20mg
- 25mg
- 30mg
- 40mg
- 50mg
- 100mg
- 125mg
- 200MG
- 250mg
- 350mg
- 500mg
- 1gm
- 1ML
- 1000mg
- 1g
- 2g
- 2.5g
- 5ML
- 5g
- 5gm
- 10g
- 10gm
- 25g
- 25gm
- 25mL
- 50g
- 100gm
- 500mL
- IND837-1G
- 100g
- 100mL
- 250gm
- 250g
- 500g
- 500gm
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 1MT
- 18%
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 500kg
- 100
- 200
- 25
- 250kgs
- 50
- 1and gm
- 1Gms
- 25kgs
- 100Gms
- 300grams
- 250250 mg.
- 0.18
- 5Gms
- 25Gms
2-(2 ethoxyphenoxy)ethyl bromide 3259-03-8.
Isopropyl hydrazine Hydro chloride 16726-41-3
2,2,14,14-tetramethyl-8-oxopentadecanedioic acid 413624-71-2
N-(2-methyl - 5- amino phenyl)-4-(3-pyridyl)-2-pyrimidine 152460-10-1
Sitagliptin Ketoamide Impurity 764667-65-4
N-(p-tolylsulfonylmethyl)formamide 36635-56-0
1,4-dioxa-8-azaspiro[4.5]decane 177-11-7
N4- Benzoyl-5' -O-DMT-5-methyl-2' -deoxycytidine, Bz-DMT-5-Me-dC, 104579-03-5











